SECsense Logo

Cyclo Therapeutics, Inc. 8-K Filing: Key Updates on Securities and Corporate Actions

$CYTHW
Form 8-K
Filed on: 2023-12-28
Source
Cyclo Therapeutics, Inc. 8-K Filing: Key Updates on Securities and Corporate Actions

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Entity Information:
  • Company Name: Cyclo Therapeutics, Inc.
  • CIK (Central Index Key): 0000922247
  • SEC File Number: 001-39780
  • Tax ID: 59-3029743
  • Address: 6714 NW 16th Street, Gainesville, FL 32653
  • Contact Number: 386-418-8060
  1. Report Details:
  • Filing Type: 8-K
  • Filing Date: December 27, 2023
  1. Security Information:
  • Common Stock:
    • Par Value: $0.0001 per share
    • Ticker Symbol: CYTH (NASDAQ)
  • Warrants to Purchase Common Stock:
    • Ticker Symbol: CYTHW (NASDAQ)
  1. Period of Reporting:
  • Reporting Date: December 27, 2023
  1. Key Dimensions:
  • The filing includes categories for:
    • Common Stock Par Value
    • Warrants to Purchase Common Stock

Insights:

  • The report indicates a significant corporate action or event reported under Form 8-K, which is typically used to report major events that shareholders should know about. The precise nature of the event is not detailed in the provided text but may be critical for stakeholders.
  • The company is listed on NASDAQ, indicating it is a publicly traded entity, which may influence stock liquidity and investor interest.
  • The presence of warrants suggests potential future capital raising opportunities or stockholder dilution depending on the exercise of these warrants.
  • The specific par value of the common stock is noted, which is relevant for accounting and financial reporting standards.

Overall, this section indicates a recent filing event by Cyclo Therapeutics, Inc. that may have implications for its securities and shareholder value. Further context from the full 8-K filing would be necessary to assess the impact of the reported event more thoroughly.